Expansion through Acquisition The recent acquisition by Sirio Pharma in January 2023 has expanded Best Formulations' operational reach across three continents, offering new opportunities to collaborate with a global network of pharmaceutical and nutritional brands seeking localized manufacturing capabilities.

Robust Market Presence With an annual revenue range of $100 million to $250 million and over 201 employees, Best Formulations exhibits strong market positioning as a full-scale contract manufacturer, signaling potential for partnerships with emerging brands needing scalable production capacity.

Quality-Driven Heritage Founded on a foundation of uncompromising quality since 1984, highlighted by the retention of their original blending equipment, the company appeals to clients prioritizing high-quality, controlled production standards, ideal for premium supplement and pharmaceutical brands.

Technological Integration Utilization of advanced tech stack including SAP, Power BI, and UKG indicates a focus on efficient operations and data-driven decision-making, providing opportunities for innovative solutions and automation services to optimize client manufacturing processes.

Growth Potential As part of Sirio Pharma's strategic growth plan, there is significant potential to leverage Best Formulations’ extensive industry experience and manufacturing expertise to capture additional market segments, especially companies seeking reliable contract manufacturing with a strong quality pedigree.